PERSONAL DATA: AGE: 71 years HEIGHT: 175 cm WEIGHT: 75 kg PSA TEST RESULTS: 12/04/2024 …… 4.2 ng/mL …… <4 ng/mL...

Understanding Your Prostate MRI Results

Thank you for sharing your [ID removed] I can help you understand what these findings mean in educational context. Let me walk through your PSA results and MRI findings.

---

Your PSA Trend (December 2024 - February 2025)

Looking at your PSA values over the past 3 months:

| Date | PSA Level | Reference Range | |------|-----------|-----------------| | [date removed] | 4.2 ng/mL | <4 ng/mL | | [date removed] | 3.97 ng/mL | <4 ng/mL | | [date removed] | 4.11 ng/mL | <4 ng/mL | | [date removed] | 5.09 ng/mL | <4 ng/mL | | [date removed] | 5.14 ng/mL | <4 ng/mL |

What this means: Your PSA has been mostly stable around 4 ng/mL, with a slight rise in February 2025 to 5.14 ng/mL. According to NCCN Guidelines, PSA levels can be affected by age, prostate size, urinary tract infections, and other factors—not just cancer. A single elevated reading doesn't automatically indicate cancer, but the trend is worth monitoring.

---

Your MRI Findings Explained

Your multiparametric MRI (a detailed imaging test) identified a PI-RADS 4 lesion in your left prostate. Let me break down what this means:

What is PI-RADS?

PI-RADS is a scoring system (1-5) that radiologists use to describe how suspicious a prostate lesion (abnormal area) appears on MRI:

• PI-RADS 1-2: Likely benign (not cancer)
• PI-RADS 3: Intermediate concern
• PI-RADS 4-5: Higher suspicion for clinically significant cancer

Your Specific Findings:

The lesion itself:

• Location: Apex (tip) of the left lobe, lower portion (3-5 o'clock position)
• Size: 1 cm (about the size of a small pea)
• Characteristics:
  • Shows "restricted diffusion" (water movement is limited—a sign often seen with cancer cells)
  • Shows "intense early contrast enhancement" (takes up dye quickly—another suspicious feature)
  • Causes mild indentation of the prostatic capsule (the outer lining)

Good news in your report:

• Seminal vesicles (storage glands) appear normal
• No enlarged lymph nodes visible
• Bladder wall looks normal
• Mild adenomatous hyperplasia in the transition zone (common benign enlargement in older men)

---

What NCCN Guidelines Say About This Situation

According to NCCN Guidelines for Prostate Cancer, when imaging shows a suspicious lesion like yours, the clinical approach typically involves:

1. Risk stratification — Doctors combine your PSA level, age, imaging findings, and digital rectal exam results to assess overall risk
2. Consideration of biopsy — A PI-RADS 4 lesion with your PSA trend may warrant further evaluation through biopsy to determine if cancer is present
3. Shared decision-making — Your urologist will discuss whether biopsy is appropriate for YOUR specific situation

---

Important Context About Your Case

Your May 2024 urologist visit found:

• Normal digital rectal exam
• Normal ultrasound
• Normal responses to screening questionnaire

However, the February 2025 MRI is more detailed than ultrasound and has identified a lesion that warrants attention. This doesn't mean you definitely have cancer—PI-RADS 4 lesions can sometimes be benign—but it does mean your doctor will likely recommend further evaluation.

---

Questions to Ask Your Urologist

Based on your findings, here are specific questions that will help you understand your next steps:

1. "Based on my PI-RADS 4 lesion and my PSA trend, do you recommend a prostate biopsy? Why or why not?"

2. "What are the risks and benefits of biopsy versus monitoring with repeat MRI?"

3. "If we do a biopsy, what type will you use, and what should I expect?" (Doctors typically use ultrasound-guided or MRI-guided biopsy for lesions like yours)

4. "How often should my PSA be monitored, and when should I have follow-up imaging?"

5. "Are there any clinical trials I should know about for prostate cancer evaluation or early-stage disease?" (You can also search ClinicalTrials.gov for prostate cancer studies in your area)

---

What Happens Next

Your urologist will determine the best path forward based on:

• Your complete clinical picture (age, health status, life expectancy)
• Your preferences and comfort level with biopsy
• Whether monitoring versus biopsy aligns with your goals of care

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.